Skip to content

The antifungal effect of Royal jelly on vaginal candidiasis

The evaluation of the antifungal effect of Royal jelly on vaginal candidiasis; clinical randomized trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220210053988N1
Enrollment
90
Registered
2023-01-17
Start date
2021-03-21
Completion date
Unknown
Last updated
2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vaginal candidiasis.

Interventions

Intervention 1: Intervention group: This group consists of 45 patients which take royal jelly 1000 mg per day for ten days. The royal jelly used in this study with name Tang Forte is produced under l

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Married women Age between 18-50 vaginal infection sign and symptoms

Exclusion criteria

Exclusion criteria: Pregnancy and breastfeeding immune compromise patients organ transplantation cancer renal and liver disease resistant treatment bacterial and fungal infections

Design outcomes

Primary

MeasureTime frame
The average candida culture. Timepoint: From patients with vaginal signs we make the first culture test and set to lab. After the approval of the positive test of vaginal culture, the patients in the group receiving the royal jelly supplement, receive royal jelly at a dose of 1000 mg daily for 10 days. The second group that receive clotrimazole ( control group), patients receive clotrimazole for ten nights, each night one applicator. Then we make the second culture test for both groups. We compare the results for two groups. Method of measurement: cultivation environment for candidia, spaculum, swap.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Ramazanichaleshtori

Iran University of Medical Sciences

dr.m.ramazani.m@gmail.com+98 31 3391 3183

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026